Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07091851 · ClinicalTrials.gov registry record · NA

BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement

A NA study of Hypertension and Stroke, sponsored by Massachusetts General Hospital.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07091851: Recruiting NA study of Hypertension and Stroke, sponsored by Massachusetts General Hospital.

NCT07091851 is a NA study of Hypertension and Stroke that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 50 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07091851, a NA study of Hypertension and Stroke, is actively recruiting participants, sponsored by Massachusetts General Hospital.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The investigators want to improve care for people who have had a stroke. High blood pressure is the leading cause for having a second stroke and can lead to poor brain health. The goal of this study is to compare two new ways of lowering blood pressure. The first way is to help people check their blood pressure at home. The second way is to bring people together and learn about blood pressure in a group setting. The study team thinks that using both methods together will make it easier to lower blood pressure after a stroke. The study team needs this study to test these two methods together in people who have had a stroke. The investigators believe this is an important study because having high blood pressure makes having another stroke very likely. Therefore, the investigators want to lower blood pressure in people with strokes to keep their brains as healthy as possible and to help with stroke recovery.

Primary Outcome

mean systolic blood pressure

Interventions

  • BEHAVIORAL Group medical visits and home blood pressure monitoring

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-09-22
Est. Completion 2028-04-30
Phase NA
Massachusetts General Hospital

2,032 total trials

What NCT07091851 shows while recruiting

NCT07091851 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).

The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Group medical visits and home blood pressure monitoring is the first listed.

NCT07091851 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07091851 about?

NCT07091851 is a clinical study titled "BRIDGE: Blood Pressure Reduction and Intervention Delivery Via Group Engagement". The investigators want to improve care for people who have had a stroke. High blood pressure is the leading cause for having a second stroke and can lead to poor brain health. The goal of this study is to compare two new ways of lowering blood pressure. The first way is to help people check their bl...

What is the current status of trial NCT07091851?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-09-22. Estimated completion is 2028-04-30.

What conditions does trial NCT07091851 study?

This clinical trial studies the following conditions: Hypertension, Stroke, Implementation Research, Home Blood Pressure Monitoring.

What interventions are being tested in trial NCT07091851?

The interventions under investigation include: Group medical visits and home blood pressure monitoring (BEHAVIORAL).

Who is sponsoring clinical trial NCT07091851?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07091851 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07091851's enrollment target sits among peer trials

50 367th of 470 higher than 96 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07091851, the US trial registry maintained by the National Library of Medicine. NCT07091851 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.